Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep-Oct;110(5):417-21.

Management of amyotrophic lateral sclerosis

Taha Bali  1 , Timothy M Miller
Affiliations
Review

Management of amyotrophic lateral sclerosis

Taha Bali et al. Mo Med. 2013 Sep-Oct.

Abstract

Motor Neuron Diseases (MNDs) are neurological disorders characterized by the selective and progressive degeneration of motor neurons. Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is the most common. ALS causes diffuse muscle weakness and death secondary to respiratory failure. The diagnosis is made clinically, supported by electrodiagnostic testing. Although medications are limited, careful attention to breathing, nutrition, and patient mobility can have a major, positive impact on the course of the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intrinsic hand muscle atrophy commonly seen in ALS patients.
None
None
See this image and copyright information in PMC

References

    1. Bedlack RS, Mitsumoto H. Amyotrophic lateral sclerosis : a patient care guide for clinicians
    1. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002 Jul 23;59(2):280–282. - PubMed
    1. Johnston CA, Stanton BR, Turner MR, et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol. 2006 Dec;253(12):1642–1643. - PubMed
    1. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology. 1999 Feb;52(3):504–509. - PubMed
    1. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011 Oct 20;72(2):257–268. - PMC - PubMed

Publication types

MeSH terms